Key facts
- Norcliffe Capital is a venture capital firm based in London, England with 7 tracked portfolio companies.
- Notable positions include Biosceptre, SMi Systems, Dxcover, Oxford Endovascular, Santersus.
- The team roster lists 2 people.
About Norcliffe Capital
Founded in 2018, Norcliffe Capital is a venture capital firm based in London, United Kingdom. The firm seeks to directly invest in innovative UK companies within the life science sector with the potential to achieve exponential growth. The firm provides seed, pre-series and series A funding to companies.
Free account
See the whole book
- ·Watchlist + alerts for Norcliffe Capital's activity
Create free account
No card required
Portfolio, priced
7 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Biosceptre | — | $431.9M | — | |
| SMi Systems | — | $52.6M | — | |
| Dxcover | — | $37.8M | — | |
| Oxford Endovascular | — | $36.8M | — | |
| Santersus | — | $19.9M | — | |
| 4D Medicine | — | $17.8M | — | |
| Laverock Therapeutics | — | — | — |
Team
2 people on record — 2 with verified contacts
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked
- What companies does Norcliffe Capital invest in?
- Norcliffe Capital has 7 recorded portfolio companies, including Biosceptre, SMi Systems, Dxcover, Oxford Endovascular.
- What is Norcliffe Capital's AUM?
- Norcliffe Capital manages approximately $67.7M in assets.